1344 Results for "

Prosopis juliflora (Sw.) DC.

" in MedChemExpress (MCE) Product Catalog:
Products (1344)

1344 Results for "Prosopis juliflora (Sw.) DC." in MCE Product Catalog:

33
33 Publications Verification
Art. -Nr.: HY-P80137
Synonyms: GAPDH; GAPD; CDABP0047; OK/SW-cl.12; Glyceraldehyde-3-phosphate dehydrogenase; Peptidyl-cysteine S-nitrosylase GAPDH

Host:  

Rabbit

Application:  

WB, ICC/IF, IHC-P, FC, IP

Reactivity:  

Human, Mouse, Rat, Chicken

loading...
    loading...
20
20 Cited Publications
Art. -Nr.: HY-13962
CAS. Nr.: 1020149-73-8
Reinheit:  99.77%
Forschungsgebiete:  

Cancer

SGI-1027 is a DNA methyltransferase (DNMT) inhibitor, with IC50s of 7.5 μM, 8 μM, and 12.5 μM for DNMT3B, DNMT3A, and DNMT1 with poly(dI-dC) as substrate.
loading...
    loading...
12
12 Cited Publications
Art. -Nr.: HY-15594A
CAS. Nr.: 929895-45-4
Reinheit:  98.99%
Synonyms: Phen-DC3 Triflate
Phen-DC3 Trifluoromethanesulfonate is a bisquinolinium G-quadruplex (G4) ligand. Phen-DC3 Trifluoromethanesulfonate selectively binds to and stabilizes the hybrid quadruplex-duplex hybrid (QDH) derived from the PIM1 promoter. Phen-DC3 Trifluoromethanesulfonate also binds to the c-myc promoter Pu24T G4 via extensive π-stacking, and induces polymerase stalling at α-synuclein DNA and RNA G4 sequences. Phen-DC3 Trifluoromethanesulfonate downregulates LPS (HY-D1056)-induced TNFRSF21, RIPK3 and p-MLKL in VECs, and ameliorates CLP-induced pulmonary vascular leakage in septic rats. Phen-DC3 Trifluoromethanesulfonate can be used in studies related to neurodegenerative diseases and sepsis-associated vascular injury .
loading...
    loading...
11
11 Cited Publications
Art. -Nr.: HY-128359
CAS. Nr.: 2375564-55-7
Reinheit:  99.92%
Forschungsgebiete:  

Cancer

ACBI1 is a potent and cooperative SMARCA2, SMARCA4 and PBRM1 degrader with DC50s of 6, 11 and 32 nM, respectively. ACBI1 is a PROTAC degrader. ACBI1 shows anti-proliferative activity. ACBI1 induces apoptosis .
loading...
    loading...
11
11 Cited Publications
Art. -Nr.: HY-N0264
CAS. Nr.: 1124-11-4
Synonyms: Chuanxiongzine; Tetramethylpyrazine
Ligustrazine (Chuanxiongzine) is an orally active, blood-brain barrier-permeable alkaloid. It can be isolated from Ligusticum striatum DC. Ligustrazine reduces ROS, upregulates the levels of p-Akt/Akt and p-eNOS/eNOS, and decreases ALT and AST. It inhibits glutamate excitotoxicity, calcium overload, oxidative stress, ischemia-reperfusion injury and atherosclerotic plaque progression, enhances synaptic plasticity, and improves neurological function, cerebral infarct volume and brain water content. Ligustrazine possesses anti-inflammatory, antioxidant, lipid-lowering, endothelial protective and hepatoprotective activities. It can be used in studies related to ischemic stroke, cerebral ischemia-reperfusion injury and atherosclerosis .
loading...
    loading...
11
11 Cited Publications
Art. -Nr.: HY-N0935
CAS. Nr.: 76494-51-4
Synonyms: Chuanxiongzine hydrochloride; Tetramethylpyrazine hydrochloride
Ligustrazine hydrochloride (Chuanxiongzine hydrochloride) is an orally active, blood-brain barrier-permeable alkaloid. It can be isolated from Ligusticum striatum DC. Ligustrazine hydrochloride reduces ROS, upregulates the levels of p-Akt/Akt and p-eNOS/eNOS, and decreases ALT and AST. It inhibits glutamate excitotoxicity, calcium overload, oxidative stress, ischemia-reperfusion injury and atherosclerotic plaque progression, enhances synaptic plasticity, and improves neurological function, cerebral infarct volume and brain water content. Ligustrazine hydrochloride possesses anti-inflammatory, antioxidant, lipid-lowering, endothelial protective and hepatoprotective activities. It can be used in studies related to ischemic stroke, cerebral ischemia-reperfusion injury and atherosclerosis .
loading...
    loading...
10
10 Cited Publications
Art. -Nr.: HY-109049
CAS. Nr.: 1467093-03-3
Reinheit:  98.85%
Synonyms: SM04690; Lorecivivint
Target:  

Wnt

Forschungsgebiete:  

Inflammation/Immunology Cancer

Adavivint (SM04690; Lorecivivint) is a potent and selective inhibitor of canonical Wnt signaling, with an EC50 of 19.5 nM via a high-throughput TCF/LEF-reporter assay in SW480 colon cancer cells .
loading...
    loading...
10
10 Cited Publications
Art. -Nr.: HY-P80670
Synonyms: FTH1; FTH; FTHL6; OK/SW-cl.84; PIG15; Ferritin heavy chain; Ferritin H subunit; Cell proliferation-inducing gene 15 protein

Host:  

Rabbit

Application:  

WB, ICC/IF

Reactivity:  

Human, Mouse, Rat, Hamster

loading...
    loading...
9
9 Cited Publications
Art. -Nr.: HY-101943
CAS. Nr.: 10538-99-5
Reinheit:  ≥98.0%
Forschungsgebiete:  

Cancer

LY 345899 is a Folate analog and is a methylene tetrahydrofolate dehydrogenase (MTHFD1; DC301) and MTHFD2 inbhibitor with IC50 values of 96 nM and 663 nM, respectively and a Ki of 18 nM for MTHFD1 .
loading...
    loading...
9
9 Cited Publications
Art. -Nr.: HY-138642
CAS. Nr.: 2229711-68-4
Reinheit:  99.60%
Synonyms: ARV-471; PF-07850327
Forschungsgebiete:  

Cancer

Vepdegestrant (ARV-471) is an orally active PROTAC estrogen receptor degrader against breast cancer. Vepdegestrant is a hetero-bifunctional molecule that facilitates the interactions between estrogen receptor alpha and an intracellular E3 ligase complex. Vepdegestrant leads to the ubiquitylation and subsequent degradation of estrogen receptors via the proteasome. Vepdegestrant robustly degrades ER in ER-positive breast cancer cell lines with a half-maximal degradation concentration (DC50) of about 2 nM .
loading...
    loading...
8
8 Cited Publications
Art. -Nr.: HY-16968
CAS. Nr.: 459147-39-8
Target:  

15-PGDH

Forschungsgebiete:  

Others

SW033291 is a potent and high-affinity inhibitor of 15-PGDH with a Ki of 0.1 nM. SW033291 increases prostaglandin PGE2 levels in bone marrow and other tissues. SW033291 also promotes tissue regeneration .
loading...
    loading...
8
8 Cited Publications
Art. -Nr.: HY-119932
CAS. Nr.: 2301916-69-6
Reinheit:  99.25%
Target:  

PROTACs FAK Akt

Forschungsgebiete:  

Cancer

PROTAC FAK degrader 1 (Compound PROTAC-3) is a selective and effective degrader of Fak PROTAC with a DC50 of 3.0 nM. PROTAC FAK degrader 1 reduces the ability of cancer cells to migrate and invade. PROTAC FAK degrader 1 can be used in the study of tumor .
loading...
    loading...
7
7 Cited Publications
Art. -Nr.: HY-154919
Reinheit:  99.52%
Forschungsgebiete:  

Endocrinology Cancer

DC-Y13-27 is a DC-Y13 derivative and YTHDF2 inhibitor (KD: 37.9 μM). DC-Y13-27 inhibits YTHDF2, restores FOXO3 and TIMP1 protein levels, and reduces MMP1/3/7/9 expression. DC-Y13-27 induces Pyroptosis and increases IL-1β secretion. DC-Y13-27 reduces intervertebral disc degeneration and enhances the response to radiotherapy in colon cancer and melanoma. DC-Y13-27 has antitumor activity against breast cancer .
loading...
    loading...
7
7 Cited Publications
Art. -Nr.: HY-12032
CAS. Nr.: 328543-09-5
Reinheit:  99.44%
Target:  

PARP

Forschungsgebiete:  

Cancer

AG14361 is a potent PARP-1 inhibitor, with a Ki of < 5 nM, and in permeabilized SW620 and intact SW620 cells, the IC50s are 29 nM and 14 nM, respectively.
loading...
    loading...
6
6 Cited Publications
Art. -Nr.: HY-111621
CAS. Nr.: 1872387-43-3
Reinheit:  99.53%
Target:  

Autophagy Apoptosis

Forschungsgebiete:  

Cancer

DC661 is a potent palmitoyl-protein thioesterase 1 (PPT1) inhibitor, inhibits autophagy, and acts as an anti-lysosomal agent. Anti-cancer activity .
loading...
    loading...
6
6 Cited Publications
Art. -Nr.: HY-107636
CAS. Nr.: 497061-48-0
Reinheit:  99.97%
Target:  

Apoptosis

Forschungsgebiete:  

Cancer

DC_AC50 is a dual inhibitor of Atox1 and CCS (copper chaperones). Inhibiting intracellular copper chaperones as a means of reducing/preventing acquired chemotherapy resistance .
loading...
    loading...
6
6 Cited Publications
Art. -Nr.: HY-109176
CAS. Nr.: 1953133-47-5
Reinheit:  99.52%
Synonyms: GDC-9545; RG6171
Target:  

Estrogen Receptor/ERR

Forschungsgebiete:  

Endocrinology Cancer

Giredestrant (GDC-9545) is an orally active, full, selective Estrogen receptor α (ERα) degrader and antagonist with a DC50 of 0.03 nM. Giredestrant promotes the degradation of ERα protein, including the ESR1 Y537S mutant ERα. Giredestrant reduces uterine wet weight in immature rats and induces a low cuboidal phenotype in their endometrial epithelium. Giredestrant induces tumor regression in both ESR1 Y537S mutant and wild-type ERα tumor models. Giredestrant can be used for the research of ER + breast cancer .
loading...
    loading...
5
5 Cited Publications
Art. -Nr.: HY-115475
CAS. Nr.: 2126744-35-0
Reinheit:  99.93%
Target:  

HDAC

Forschungsgebiete:  

Neurological Disease

SW-100, a selective histone deacetylase 6 (HDAC6) inhibitor with an IC50 of 2.3 nM, shows at least 1000-fold selectivity for HDAC6 relative to all other HDAC isozymes. SW-100 displays a significantly improved ability to cross the blood-brain-barrier .
loading...
    loading...
5
5 Cited Publications
Art. -Nr.: HY-N0119
CAS. Nr.: 18916-17-1
Synonyms: Naringin DC
Naringin Dihydrochalcone is an artificial sweetener derived from naringin. Naringin is a major flavanone glycoside obtained from tomatoes, grapefruits, and many other citrus fruits. Naringin exhibits biological properties such as antioxidant, anti-inflammatory, and antiapoptotic activities. Naringin suppresses NF-κB signaling pathway.
loading...
    loading...
5
5 Cited Publications
Art. -Nr.: HY-122562
CAS. Nr.: 2231744-29-7
Reinheit:  98.35%
Target:  

PROTACs Btk

Forschungsgebiete:  

Cancer

MT-802 is a BTK PROTAC degrader. MT-802 degrades wild-type BTK (DC50 = 14.6 nM) and BTK mutants including E41K, C481S (DC50 = 14.9 nM), C481R, C481Y, C481T, C481F, L528W, and inhibits their Y223 phosphorylation. BI-4732 can be used for the study of Ibrutinib (HY-10997)-resistant chronic lymphocytic leukemia (CLL). (Pink: BTK ligand (HY-150885), Blue: CRBN Ligand (HY-14658), Black: Linker (HY-141371), E3 ligase ligand-linker conjugate (HY-176340)) .
loading...
    loading...